Document Detail

Single dose bioavailability and pharmacokinetic study of a innovative formulation of α-lipoic acid (ALA600) in healthy volunteers.
MedLine Citation:
PMID:  22193379     Owner:  NLM     Status:  In-Data-Review    
AIM: α-Lipoic acid is an important micronutrient with several pharmacological as well as antioxidant properties. The present study was aimed to examine the human bioavailability, pharmacokinetics (PK) and tolerability of an innovative oral formulation (ALA600) containing racemic α-lipoic acid 600 mg.
METHODS: After a single 600-mg oral administration in healthy volunteers, blood samples were collected up to 8 hours post dosing, and plasma α-lipoic acid concentrations were determined by Liquid Chromatography-Mass Spectrometry (LC-MS) detection.
RESULTS: The PK data revealed a short time to reach plasma peak oncentrations (50.8± 4.2 min) with a Cmax of 6.86±1.29 µg/mL. The Cmax implying that the new pharmaceutical form positively influences absorption and absorption time. The AUC value of 5.65±0.79 µg/mL*h is the more reliable measure of new formulation bioavailability. The half-life and MRT values further show that new formulation is absorbed consistently and rapidly and is eliminated efficiently. These PK data appear to promote further refinement of present formulation. Should the authors compare the obtained data with the recent published data, the new formulation of α-lipoic acid tends to show an improvement of Cmax value (2.5-5.4 times) and AUC (1.8 times). CONCLUSIION: ALA600 formulation is characterized by rapid absorption, high bioavailability, brief half-life and low toxicity. These PK parameters could significantly increase clinical use of lipoic acid with improvement of the therapeutic effects at the cellular level and might also prove to be the most suitable formulation for chronic administration such as peripheral neuropathies.
F Mignini; M Capacchietti; V Napolioni; G Reggiardo; R Fasani; P Ferrari
Related Documents :
210069 - Evidence of agar gel electrophoresis changes of lipoprotein-x after phospholipase a and...
15826079 - Purification and partial characterization of broccoli (brassica oleracea var. italica) ...
2781519 - Stability of gels formed following coagulation of limulus amebocyte lysate: lack of cov...
7340829 - Identification of fatty acid synthetase messenger rna on free polyribosomes isolated fr...
4241689 - Studies on protein-polysaccharides from pig laryngeal cartilage. heterogeneity, fractio...
1295889 - Preparation and characterization of troponin c from bullfrog skeletal muscle.
8420979 - The rat liver ecto-atpase is also a canalicular bile acid transport protein.
16545389 - Boric acid inhibits adenosine diphosphate-ribosyl cyclase non-competitively.
15222019 - Noninvasive analyses of polyunsaturated fatty acids in human oral mucosa in vivo by fou...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva medica     Volume:  102     ISSN:  0026-4806     ISO Abbreviation:  Minerva Med.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400732     Medline TA:  Minerva Med     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  475-82     Citation Subset:  IM    
School of Pharmacy and Health Products, University of Camerino, Camerino, Macerata, Italy -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepa...
Next Document:  Peripheral arterial disease and abdominal aortic aneurysm in elderly people.